Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
Scope of the Report:
This report studies the Sexual Dysfunction Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sexual Dysfunction Drugs market by product type and applications/end industries.
The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.
The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population.
The global Sexual Dysfunction Drugs market is valued at xx million in 2017 and is expected to reach xx million by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sexual Dysfunction Drugs.
Europe also play important roles in global market, with market size of xx million in 2017 and will be xx million in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
Market Segment by Applications, can be divided into
Male
Female
Frequently Asked Questions
Table Of Content
Table of Contents
1 Sexual Dysfunction Drugs Market Overview
1.1 Product Overview and Scope of Sexual Dysfunction Drugs
1.2 Classification of Sexual Dysfunction Drugs by Types
1.2.1 Global Sexual Dysfunction Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Types in 2017
1.2.3 Oral Therapy
1.2.4 Intracavernosal Therapy
1.2.5 Hormonal Therapy
1.2.6 Transurethral Therapy
1.3 Global Sexual Dysfunction Drugs Market by Application
1.3.1 Global Sexual Dysfunction Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Male
1.3.3 Female
1.4 Global Sexual Dysfunction Drugs Market by Regions
1.4.1 Global Sexual Dysfunction Drugs Market Size (Million ) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sexual Dysfunction Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Sexual Dysfunction Drugs (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Sexual Dysfunction Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Sexual Dysfunction Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Sexual Dysfunction Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Sexual Dysfunction Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 AbbVie
2.5.1 Business Overview
2.5.2 Sexual Dysfunction Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AbbVie Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Sexual Dysfunction Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva Pharmaceutical Industries
2.7.1 Business Overview
2.7.2 Sexual Dysfunction Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda
2.8.1 Business Overview
2.8.2 Sexual Dysfunction Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Apricus Biosciences
2.9.1 Business Overview
2.9.2 Sexual Dysfunction Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Apricus Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Emotional Brain
2.10.1 Business Overview
2.10.2 Sexual Dysfunction Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Emotional Brain Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ivix LLX
2.11.1 Business Overview
2.11.2 Sexual Dysfunction Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Ivix LLX Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.12 Leadiant Biosciences
2.12.1 Business Overview
2.12.2 Sexual Dysfunction Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.13 NexMed
2.13.1 Business Overview
2.13.2 Sexual Dysfunction Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 NexMed Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.14 S1 Biopharma
2.14.1 Business Overview
2.14.2 Sexual Dysfunction Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 S1 Biopharma Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.15 Vietstar Biomedical Research
2.15.1 Business Overview
2.15.2 Sexual Dysfunction Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Sexual Dysfunction Drugs Market Competition, by Players
3.1 Global Sexual Dysfunction Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Sexual Dysfunction Drugs Players Market Share
3.2.2 Top 10 Sexual Dysfunction Drugs Players Market Share
3.3 Market Competition Trend
4 Global Sexual Dysfunction Drugs Market Size by Regions
4.1 Global Sexual Dysfunction Drugs Revenue and Market Share by Regions
4.2 North America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5 North America Sexual Dysfunction Drugs Revenue by Countries
5.1 North America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
5.2 USA Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6 Europe Sexual Dysfunction Drugs Revenue by Countries
6.1 Europe Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
6.2 Germany Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.4 France Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Sexual Dysfunction Drugs Revenue by Countries
7.1 Asia-Pacific Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
7.2 China Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.5 India Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8 South America Sexual Dysfunction Drugs Revenue by Countries
8.1 South America Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
8.2 Brazil Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Sexual Dysfunction Drugs by Countries
9.1 Middle East and Africa Sexual Dysfunction Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Sexual Dysfunction Drugs Revenue and Growth Rate (2013-2018)
10 Global Sexual Dysfunction Drugs Market Segment by Type
10.1 Global Sexual Dysfunction Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Sexual Dysfunction Drugs Market Forecast by Type (2018-2023)
10.3 Oral Therapy Revenue Growth Rate (2013-2023)
10.4 Intracavernosal Therapy Revenue Growth Rate (2013-2023)
10.5 Hormonal Therapy Revenue Growth Rate (2013-2023)
10.6 Transurethral Therapy Revenue Growth Rate (2013-2023)
11 Global Sexual Dysfunction Drugs Market Segment by Application
11.1 Global Sexual Dysfunction Drugs Revenue Market Share by Application (2013-2018)
11.2 Sexual Dysfunction Drugs Market Forecast by Application (2018-2023)
11.3 Male Revenue Growth (2013-2018)
11.4 Female Revenue Growth (2013-2018)
12 Global Sexual Dysfunction Drugs Market Size Forecast (2018-2023)
12.1 Global Sexual Dysfunction Drugs Market Size Forecast (2018-2023)
12.2 Global Sexual Dysfunction Drugs Market Forecast by Regions (2018-2023)
12.3 North America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.6 South America Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Sexual Dysfunction Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Inquiry For Buying
Sexual Dysfunction Drugs
Request Sample
Sexual Dysfunction Drugs
